'Adverse event' won't impact Covishield licensing, says Health Secretary Rajesh Bhushan

Serum Institute, too, has denied allegation of side-effect of Covishield, a Covid-19 vaccine candidate it developed along with Oxford University and AstraZeneca, saying the complainant Chennai volunteer's condition was "in no way induced by the vaccine".

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/36tshso
via IFTTT